ABSTRACT The diterpene tumor promoters enhance the proliferation in culture of myeloid and erythroid precursor cells from normal mouse hemopoietic tissues. The effect is observed only with those diterpenes that are tumor promoters, including 12-O-tetradecanoylphorbol 13-acetate (TPA); diterpenes that are inactive as tumor promoters are ineffective as stimulators of colony formation. Tumor promoters act synergistically with suboptimal concentrations of conditioned medium used as a source of colony-stimulating factor (CSF) to increase both the number and size of myeloid colonies. Formation of myeloid colonies is stimulated by tumor promoters even without addition of CSF. Both pure and mixed granulocyte/macrophage colonies develop; high concentrations (>100 gg/ml) of TPA are more favorable for macrophage colony formation. In erythropoietin-stimulated cultures, tumor promoters enhance the development of relatively early and intermediate erythroid precursors, whereas later erythroid precursors are unaffected Tumor promoters are compounds that are not carcinogenic but enhance tumor formation when administered after a low dose of a carcinogen (1-3). 12-O-Tetradecanoylphorbol 13-acetate (TPA) and some related plant diterpene esters that promote tumors in mouse skin demonstrate a number of biological and biochemical effects in cells in culture (4). It has been reported (5-10) that these compounds can have different effects on cell differentiation depending on the nature of cells. Tumor promoters inhibit terminal differentiation of several cultured cell lines (4); for example, in TPA-sensitive clones of murine erythroleukemia cells (11), tumor promoters inhibit the exprinon of erythroid functions (12). On the other hand, in Rauscher virus-transformed murine erythroid cell lines (13), TPA stimulates erythroid differentiation. In some murine (14) and human myeloid leukemia cell lines (15) (16) (17) , TPA stimulates the cells to undergo differentiation along the monocytic pathway.
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In the present studies we investigated the effect of tumorpromoting agents on the in vitro development of normal murine hemopoietic cells, specifically, myeloid precursor cells (CFU-c), which produce colonies of granulocytes and macrophages (18) , and erythropoietic precursor cells, including erythroid burst-forming units (BFU-e), which produce macroscopic colonies of hemoglobinized cells and more mature erythroid precursors, the erythroid colony forming units (CFU-e), which produce small colonies of hemoglobinized cells (19, 20) . CFU-e are considered to be the progeny of BFU-e (21) . In this study we report that tumor-promoting plant diterpenes stimulate proliferation of normal mouse bone marrow-derived CFU-c and BFU-e, but have no effect on MAM 2-mercaptoethanol. One milliliter of this cell suspension was dispensed into 35 X 10 mm petri dishes (non-tissue-culture dish, catalog no. 5221-R, Lux). Colony-stimulating factor (CSF) was provided in the form of lung conditioned medium (CM), prepared and assayed as previously described (23) ; human urinary erythropoietin (Blood Diseases Branch, National Heart and Lung Institute, Bethesda, MD), or various plant diterpenes were added to the semisolid cloning medium prior to the addition of the cell mixture. Two culture plates were placed in a 100-mm petri dish containing a third dish filled with water and incubated in a humidified atmosphere of 95% air and 5% CO2 at 370C. Colonies were counted with an inverted microscope. Erythroid colonies were enumerated after 2-3 days of incubation, counting all clusters of eight or more hemoglobinized cells (CFU-e). Clusters of more than 32 hemoglobinized cells were counted on day 5 and scored as intermediate erythroid bursts (5dBFU-e). Large aggregates of hemoglobinized cells were counted on day 9 and scored as late bursts (9dBFU-e). Granulocyte/macrophage colonies (CFU-c) containing more than 40 cells were counted on day 7 unless otherwise stated. The cellular composition of the colonies was further analyzed by picking individual colonies, preparing a smear on a glass slide, and staining with benzidine and then with May/Grunwald Giemsa (24) . Each study was repeated at least four times, and results are expressed as the mean value. The standard deviation for each mean value did not exceed 20%.
Chemicals. TPA, phorbol, phorbol 12,13-didecanoate (PDD), and 4a-phorbol 12,13-didecanoate (4a-PDD) were purchased from Consolidated Midland, Brewster, NY. MezAbbreviations: TPA, 12-0-tetradecanoylphorbol 13-acetate; PDD, phorbol 12,13-didecanoate; CSF, colony stimulating activity; CM, conditioned medium; CFU-c, myeloid colony-forming units; CFU-e, erythroid colony-forming units; 5dBFU-e, 5-day erythroid burstforming units; 9dBFU-e, 9-day erythroid burst-forming units. 
RESULTS
Effect of tumor promoters on myeloid cells As previously reported (18) , the development of CFU-c is dependent on the addition of CSF. In the presence of CM at concentrations lower than 0.75% almost no colonies appeared. The optimal concentration of CM for colony formation was 6%.
Addition of TPA to the cultures increased both the number and size of CFU-c colonies that developed in concentrations of CM below 6%. In the absence of added CM tumor promoters induced considerable CFU-c colony formation (Fig. 1) (4) .
The enhancing effect of TPA on proliferation of CFU-c is noted not only when TPA is added at the time of initiation of cultures, but also when it is added 2, 4, or 6 days after initiation of cultures without CM or with low concentrations of CM (Fig.  4) . Not only the number of the colonies but also their size was augmented. (21) . After 2-S days in culture, small colonies of 8-32 hemoglobinized cells appear (CFU-e type colonies). The development of these colonies was not affected by the addition of TPA (Fig. 5) . After 5 Erythropoietin, units/ml FIG. 5 . TPA effect on CFU-e and 9dBFU-e derived colony formation. Mouse fetal liver cells were cloned at 2 X 105 per plate with various concentrations of erythropoietin with (-, A) or without (o, A) TPA at 100 ng/ml. o and N, CFU-e colonies; and A, 9dBFU-e colonies. CFU-e colonies were scored on day 3 and 9dBFU-e on day 9, according to criteria described in the text.
bursts developed (9dBFU-e). TPA increases both the number and size of 5dBFU-e and 9dBFU-e bursts. In (12) . It has been suggested that the murine erythroleukemia cell is a transformed variant of the murine BFU-e or a closely related cell (25) .
The mechanism of action of the tumor promoter effect is unclear. A number of possible mechanisms can be suggested, and more than one mechanism may be involved. (i) Inhibition of cell differentiation: tumor promoters inhibit the terminal stages of differentiation of murine erythroleukemia cells (9, 10, 12) . In the presence of tumor promoters, murine erythroleukemia cells retain their potential for cell multiplication (12) . By analogy it may be suggested that tumor promoters affect normal hemopoietic precursors by delaying differentiation, increasing the number of cell division cycles before the stage of terminal differentiation at which they can no longer divide.
(ii) A direct mitogenic effect: TPA is a known mitogen for human lymphocytes (27 (28) . Conditioned media prepared in this manner are also reported to enhance erythroid burst, but not colony, formation; this activity is termed burst-promoting activity (29) . Such material is able to stimulate erythroid bursts even without addition of erythropoietin (30) . (iv) Modification of the interaction between target cell and the appropriate growth factor: TPA has been shown to alter cellular affinity for epidermal growth factor in various human and mouse cells (31) . TPA may, in an analogous fashion, enhance the responsiveness of hematopoietic precursors to erythropoietin or CSF.
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